May 14, 2026 08:30AM
May 13, 2026 07:11AM
May 6, 2026 08:00AM
Apr 10, 2026 08:01AM
Apr 10, 2026 08:00AM
Apr 7, 2026 08:30AM
Apr 2, 2026 08:00AM Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 31, 2026 08:00AM
Mar 16, 2026 08:13AM
Mar 12, 2026 08:00AM
Feb 26, 2026 08:00AM
Feb 10, 2026 08:03AM
Feb 10, 2026 08:00AM
Feb 3, 2026 08:00AM Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 26, 2026 08:02AM
Jan 26, 2026 08:00AM
Jan 13, 2026 06:09AM
Jan 6, 2026 08:02AM
Jan 6, 2026 08:00AM
Dec 21, 2025 04:00AM
Dec 17, 2025 05:00PM Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Dec 17, 2025 05:00PM
Dec 15, 2025 10:03AM
Dec 12, 2025 08:00PM
Dec 12, 2025 08:00PM
Nov 12, 2025 07:01AM
Nov 4, 2025 04:05PM
Nov 3, 2025 08:00AM Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025
Oct 9, 2025 08:00AM
Aug 19, 2025 08:00AM
Aug 12, 2025 07:05AM
Jul 11, 2025 09:32AM
Jul 11, 2025 09:30AM
Jul 11, 2025 06:02AM
Jul 11, 2025 06:01AM Milestone Pharmaceuticals Announces Proposed Public Offering
Jul 11, 2025 06:00AM
Jul 11, 2025 06:00AM
Jun 17, 2025 06:39AM
Jun 16, 2025 08:03AM
Jun 16, 2025 08:00AM
May 14, 2025 07:04AM
Apr 10, 2025 08:30AM Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens
Apr 1, 2025 06:13AM
Mar 28, 2025 07:00AM
Mar 28, 2025 07:00AM
Mar 20, 2025 08:00AM
Mar 18, 2025 06:44AM
Mar 13, 2025 07:08AM
Feb 19, 2025 08:01AM Milestone Pharmaceuticals (MIST) Notice of Allowance on New U.S. Patent for Etripamil
Feb 19, 2025 08:00AM

322,967 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All